![Top 5 things to watch in markets in the week ahead](https://i-invdn-com.investing.com/news/moved_small-LYNXNPEK340EF_L.jpg)
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 1.620 | 1.800 | 0.180 |
Stocks | 98.380 | 98.380 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 34.145 | 33.521 |
Price to Book | 5.166 | 4.784 |
Price to Sales | 4.646 | 4.665 |
Price to Cash Flow | 23.438 | 24.218 |
Dividend Yield | 0.869 | 0.739 |
5 Years Earnings Growth | 18.419 | 17.530 |
Number of long holdings: 33
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Sun Pharma | INE044A01036 | 13.37 | 1,519.80 | +0.23% | |
Lupin | INE326A01037 | 7.74 | 1,626.00 | +2.69% | |
Divi's Labs | INE361B01024 | 7.52 | 4,590.90 | +1.52% | |
Cipla | INE059A01026 | 6.26 | 1,482.00 | +0.07% | |
Apollo Hospitals | INE437A01024 | 5.29 | 6,190.00 | -0.04% | |
Dr Reddy’s Laboratories | INE089A01023 | 4.45 | 6,400.00 | +2.63% | |
Gland | INE068V01023 | 4.37 | 1,825.30 | +0.44% | |
Zydus Lifesciences | INE010B01027 | 3.77 | 1,078.60 | +2.04% | |
Vijaya Diagnostic Centre | INE043W01024 | 3.59 | 747.50 | -0.79% | |
J.B. Chemicals&Pharma | INE572A01036 | 3.16 | 1,754.05 | +4.30% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Reliance Small Cap Fund Dir Div | 515.66B | 13.19 | 33.51 | 26.46 | ||
Reliance Small Cap Fund Bonus | 515.66B | 12.81 | 32.36 | 25.25 | ||
Reliance Small Cap Fund Dividend | 515.66B | 12.01 | 33.51 | 25.58 | ||
Reliance Small Cap Fund Growth | 515.66B | 12.81 | 32.36 | 25.25 | ||
Reliance Small Cap Fund Dir Bon | 515.66B | 13.19 | 33.51 | 26.46 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review